Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Erica Marchlik"'
Autor:
Razelle Kurzrock, Jennifer L. Carter, Sheryl K. Elkin, Erica Marchlik, Vivek Subbiah, Shumei Kato
Purpose: Aberrations in genetic sequences encoding the tyrosine kinase receptor RET lead to oncogenic signaling that is targetable with anti-RET multikinase inhibitors. Understanding the comprehensive genomic landscape of RET aberrations across multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19ff9d92afdf8ce7fe17bbefd310cef3
https://doi.org/10.1158/1078-0432.c.6526431.v1
https://doi.org/10.1158/1078-0432.c.6526431.v1
Autor:
Razelle Kurzrock, Jennifer L. Carter, Sheryl K. Elkin, Erica Marchlik, Vivek Subbiah, Shumei Kato
Supplemental Table 1. Selected ongoing clinical trials targeting RET aberrations; Supplemental Table 2. Cancer diagnosis that were negative for RET aberration (included cases with N {greater than or equal to}10); Supplemental Table 3. Complete list o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ce31893ac816852f3efcdb2c1105829
https://doi.org/10.1158/1078-0432.22466784
https://doi.org/10.1158/1078-0432.22466784
Autor:
Razelle Kurzrock, Shumei Kato, Vivek Subbiah, Erica Marchlik, Jennifer L. Carter, Sheryl Krevsky Elkin
Publikováno v:
Clinical Cancer Research. 23:1988-1997
Purpose: Aberrations in genetic sequences encoding the tyrosine kinase receptor RET lead to oncogenic signaling that is targetable with anti-RET multikinase inhibitors. Understanding the comprehensive genomic landscape of RET aberrations across multi
Autor:
Dan Barnett, Jamie Randall, Sarah Mullaly, Gail Payne, Erica Marchlik, Sheryl Krevsky Elkin, Danny Rayes, Hongkun Wang, Raymond C. Wadlow, Lindsey Tishman, Timothy L. Cannon
Publikováno v:
Journal of Clinical Oncology. 39:129-129
129 Background: KRAS and NRAS (RAS) mutations are considered driver mutations in gastrointestinal malignancies such as colorectal and pancreatic cancer. Our institution obtains broad molecular testing (commercial panels with full exon coverage of at
Autor:
Erica Marchlik, Sheryl Krevsky Elkin, Razelle Kurzrock, Brett N. Tomson, Jennifer L. Carter, Philip R. Cohen
Publikováno v:
Cohen, PR; Tomson, BN; Elkin, SK; Marchlik, E; Carter, JL; & Kurzrock, R. (2016). Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics. ONCOTARGET, 7(17), 23454-23467. doi: 10.18632/oncotarget.8032. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/3xn6s72f
Oncotarget
Oncotarget, vol 7, iss 17
Oncotarget
Oncotarget, vol 7, iss 17
Merkel cell carcinoma is an ultra-rare cutaneous neuroendocrine cancer for which approved treatment options are lacking. To better understand potential actionability, the genomic landscape of Merkel cell cancers was assessed. The molecular aberration
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bcd1d62748764b0331cf58672d693d5
http://www.escholarship.org/uc/item/3xn6s72f
http://www.escholarship.org/uc/item/3xn6s72f
Autor:
G. Roger Askew, Tianhui Zhou, Victoria Roberts, Katherine A. Fitzgerald, Lih-Ling Lin, Suzana Marusic, Vincent Ling, J. Perry Hall, Nancy L. Stedman, Zhaozhao Jiang, Paresh Thakker, Mark Ryan, Erica Marchlik, Wen Kuang, Richard Pfeifer, Stephen C. Benoit, Nadege Goutagny, Thaddeus Carlson
Publikováno v:
Journal of Leukocyte Biology. 88:1171-1180
Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues, altered circulating immune cell compartments, and increased susceptibility to LPS-induced lethality. TBK1 is critical for immunity against microbial pathogens that activa